Niclosamide piperazine prevents high-fat diet-induced obesity and diabetic symptoms in mice.
CONCLUSIONS: Niclosamide piperazine salt may hold the promise to become an alternative to NEN as a drug lead for the treatment of obesity and T2D. No level of evidence Animal study.
PMID: 28780747 [PubMed - as supplied by publisher]
Source: Eating and weight disorders : EWD - Category: Eating Disorders & Weight Management Authors: Guo J, Tao H, Alasadi A, Huang Q, Jin S Tags: Eat Weight Disord Source Type: research
More News: Diabetes | Diabetes Type 2 | Diets | Eating Disorders & Weight Management | Endocrinology | High Fat | Insulin | International Medicine & Public Health | Mitochondria | Nutrition | Obesity | Parasitic Diseases | Parasitology | Sodium Chloride | Study